AbbVie breaks ground on new API facility in North Chicago
AbbVie said the site will be fully operational by 2027, enabling API production for select European and Asian products in the U.S.
AbbVie said the site will be fully operational by 2027, enabling API production for select European and Asian products in the U.S.